Introduction > Overview
Established in 1937, Queen Mary Hospital (QMH) is a major acute hospital in the Hong Kong West Cluster (HKWC) of the Hospital Authority (HA), serving a population of over 531,000 in the Central and Western and Southern Districts as well as treating many patients in other geographical districts in Hong Kong. It provides a full range of acute and tertiary services, including 24-hour Accident and Emergency (A&E) services, in-patient services, ambulatory care and rehabilitation services, as well as specialist services covering a wide range of specialties and subspecialties for the residents.
Being the teaching hospital of the Li Ka Shing Faculty of Medicine of The University of Hong Kong, QMH is responsible for providing professional clinical training, pioneering innovative technology, and conducting clinical trials for new treatment modalities. In addition, QMH serves as a tertiary and quaternary referral centre for many complex and advanced services such as organ transplant, neonatal intensive care, coronary care, burns and reconstructive surgery and neurosurgery, for the entire territory. Since July 2003, QMH has become the only designated liver transplant centre in Hong Kong to provide world-class standard liver transplant service. The A&E Department of QMH has been designated as one of the five trauma centres in the territory.
Background The redevelopment plan, featuring the use of QMH’s northern site to fit the hospital’s future service model as an academic health sciences center, involves the decanting of existing facilities of the north end of QMH complex to the ex-Senior Staff Quarters (SSQ) (which had been converted to and renamed as Block T). It presents a golden opportunity to enable the hospital to enhance its role as a premier teaching hospital, as well as further improving the hospital environment for our patients, medical students, academic partners and colleagues.
The Phase 1 Redevelopment Project of Queen Mary Hospital is conducted in two stages: